46% of patients with type 2 diabetes not on insulin reached A1C <7.0% with a continuous glucose monitor, vs. 24% in the control group, per a new NEJM study.

Join us for a postelection discussion examining what the 2026 midterm elections mean for healthcare policy and managed care leaders. 💻 Free webinar on Thursday, Nov. 5, at 12 p.m. EST  👉  Register now: hubs.li/Q04BCBXv0 #HealthcarePolicy #ManagedCare #340BReform

Vision is part of burn recovery, according to Abdullah Ahmed, a research fellow at the University of Illinois Chicago Department of Ophthalmology and Visual Sciences. Questioning patients about trouble seeing during follow-up could help identify people who need support, he said.

Up to 20% of glaucoma patients face severe vision loss even while in treatment for decades, but new virtual reality perimetry at-home testing may be able to change that, according to Jonathan Myers, M.D., the chief of glaucoma service at Wills Eye Hospital.

Get excited, HSES 2026 starts TOMORROW!🌉 The countdown is nearly over, and we can’t wait to see you there! Register now: hubs.li/Q04x3Tqs0

Time to start packing! We’re just 2 days away from the 2026 Health System Executive Summit in San Francisco! We can’t wait to welcome you! Register now: hubs.li/Q04x3T120

Just 3 days until the conversations begin. 𝟐𝟎+ 𝐒𝐩𝐞𝐚𝐤𝐞𝐫𝐬 from Providence, Sutter, UC Davis, UCSF, City of Hope and MORE! 📅 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟏𝟔 | 𝐒𝐚𝐧 𝐅𝐫𝐚𝐧𝐜𝐢𝐬𝐜𝐨 Register for FREE: hubs.ly/Q04zY2Gx0 #HSES2026 #sanfrancisco #healthcareevent #managedcare

McKesson and private equity firm CD&R will acquire Option Care Health, the largest independent home infusion company in the U.S., in a $5.8 billion deal. hubs.li/Q04zwPVj0

"The science has really outpaced our ability as a care delivery system to keep up with it." Dan Nardi of Reimagine Care on AI triage and connected devices in outpatient cancer care. hubs.li/Q04zdmNK0

Healthcare leaders are often tasked with making difficult decisions while balancing patient outcomes, organizational priorities, regulatory requirements, and financial realities. Join us for this keynote session!

New mouse data point to salt as a driver of lean MASH hubs.li/Q04z4Ltj0

UC Davis Health is checking its 340B data now so it can be ready if a rebate program takes effect Jan. 1, says chief pharmacy officer Chad Hatfield, Pharm.D., M.H.A., BCPS

Fewer than 1 in 5 young, commercially insured patients with first-episode psychosis adhered to antipsychotics in their first year of treatment, per a recent study published in JAMA Network Open. You can read the full story here: hubs.li/Q04yGq2W0

Can health systems expand access to innovative therapies while maintaining long-term financial sustainability? Watch the full interview, hubs.li/Q04r-WMl0

How can health systems prepare for the growing role of bispecifics and CAR T-cell therapies in community oncology care? Join the conversation on October 16 in San Francisco.

What does supporting women’s health look like in practice? In Part 2, we take a closer look at how Judi Health, LucyRx, and RxPreferred are approaching women’s health. Unlock Part 2 of the full article: hubs.li/Q04xVyQM0

“Head-to-head data should inform coverage decisions, but payers shouldn’t dictate therapy choice.” Experts discuss BE BOLD and what the data means for #payers, #formularies, and first-line #PsA treatment. Watch Here: hubs.li/Q04y01GW0

The best frontline regimen in #FollicularLymphoma isn’t the most intensive or the cheapest. It’s the one that controls disease while limiting toxicity, burden and total cost. Watch the Whole Episode: hubs.li/Q04x_X3D0 #Lymphoma #Oncology

The top barriers to AI use among community oncologists are lack of reimbursement (44%), training (43%) and funding (41%), according to a new J&J survey. hubs.li/Q04x_LMn0

Women’s health needs extend far beyond medication coverage. See how PBMs are approaching women’s health and where opportunities remain to improve access and outcomes. Unlock Part 1 of the full article: hubs.li/Q04xVxS80